Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design

被引:7
作者
Mullins, James I. [2 ,3 ]
Rolland, Morgane [2 ,3 ]
Allen, Todd M. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
evolution; HIV; T lymphocyte; viral proteins;
D O I
10.1097/COH.0b013e3282f233d9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The ability of human immunodeficiency virus to mutate rapidly to evade host immune pressures is a key hurdle limiting the control of human immunodeficiency virus-1 by cellular immune responses. Viral escape from CD8(+) T-cell recognition continues to be studied extensively, and emerging data provide greater appreciation of the affect of these mutations on the virus. These data may help identify key immune responses capable of suppressing viral replication. This goal remains critical, as current vaccines are unlikely to produce protective T-cell immunity. Recent findings Recent studies provide greater understanding of the propensity for transmitted mutations to revert, and of the ability of CD8(+) T-cell escape mutations to impact viral replication capacity and protein structure. These observations reveal important constraints on virus evolution and sequence diversity. Data are also accumulating for the ability of the immune system to mount de-novo CD8(+) T-cell responses against escape variants, revealing an underappreciated complexity of the process of viral escape. Summary Understanding the limits of sequence variation and the impact of immune escape mutations on viral fitness, particularly during acute infection, will be critical to guide the design of contemporary vaccines or therapeutics attempting to force human immunodeficiency viruses to become less fit.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
[31]   Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants [J].
Quirk, Erin K. ;
Brown, Elizabeth L. ;
Leavitt, Randi Y. ;
Mogg, Robin ;
Mehrotra, Devan V. ;
Evans, Robert K. ;
DiNubile, Mark J. ;
Robertson, Michael N. .
OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (01)
[32]   Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection [J].
Turriziani, O. ;
Andreoni, M. ;
Antonelli, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (10) :1518-1524
[33]   Unusual neurological manifestations of primary human immunodeficiency virus infection [J].
Hassin-Baer, S ;
Steiner, I ;
Achiron, A ;
Sadeh, M ;
Vonsover, A ;
Hassin, D .
EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (04) :369-373
[34]   High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection [J].
Braun, Dominique L. ;
Marzel, Alex ;
Steffens, Daniela ;
Schreiber, Peter W. ;
Grube, Christina ;
Scherrer, Alexandra U. ;
Kouyos, Roger D. ;
Gunthard, Huldrych F. .
CLINICAL INFECTIOUS DISEASES, 2018, 66 (05) :735-742
[35]   APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection [J].
Gourraud, P. A. ;
Karaouni, A. ;
Woo, J. M. ;
Schmidt, T. ;
Oksenberg, J. R. ;
Hecht, F. M. ;
Liegler, T. J. ;
Barbour, J. D. .
HUMAN IMMUNOLOGY, 2011, 72 (03) :207-212
[36]   Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia [J].
Jamjoom, Ghazi A. ;
Azhar, Esam I. ;
Madani, Tariq A. ;
Hindawi, Salwa I. ;
Bakhsh, Hanaa A. ;
Damanhouri, Ghazi A. .
SAUDI MEDICAL JOURNAL, 2010, 31 (09) :987-992
[37]   Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes [J].
Cheung, Joseph Y. ;
Gordon, Jennifer ;
Wang, JuFang ;
Song, Jianliang ;
Zhang, Xue-Qian ;
Prado, Fabian Jana ;
Shanmughapriya, Santhanam ;
Rajan, Sudarsan ;
Tomar, Dhanendra ;
Tahrir, Farzaneh G. ;
Gupta, Manish K. ;
Knezevic, Tijana ;
Merabova, Nana ;
Kontos, Christopher D. ;
McClung, Joseph M. ;
Klotman, Paul E. ;
Madesh, Muniswamy ;
Khalili, Kamel ;
Feldman, Arthur M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) :4432-4444
[38]   New first and second generation inhibitors of human immunodeficiency virus-1 integrase [J].
Pendri, Annapurna ;
Meanwell, Nicholas A. ;
Peese, Kevin M. ;
Walker, Michael A. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (08) :1173-1189
[39]   ETIOLOGICAL AGENTS OF DIARRHEA IN PATIENTS INFECTED BY THE HUMAN IMMUNODEFICIENCY VIRUS-1: A REVIEW [J].
Baptista Rossit, Andrea Regina ;
Musa Goncalves, Ana Carolina ;
Franco, Celia ;
Dantas Machado, Ricardo Luiz .
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2009, 51 (02) :59-65
[40]   GROWTH AND BODY-COMPOSITION IN CHILDREN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
MILLER, TL ;
EVANS, SJ ;
ORAV, EJ ;
MORRIS, V ;
MCINTOSH, K ;
WINTER, HS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1993, 57 (04) :588-592